{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:28:00Z","timestamp":1792196880309,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12951-019-0515-x","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T13:02:32Z","timestamp":1562331752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Photothermal and gene therapy combined with immunotherapy to gastric cancer by the gold nanoshell-based system"],"prefix":"10.1186","volume":"17","author":[{"given":"Jiayu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"515_CR1","first-page":"10","volume":"29","author":"T Bou Kheir","year":"2011","unstructured":"Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Gr\u00f8nb\u00e6k K, Federspiel B, Lund AH, Friis-Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer. 2011;29:10\u201329.","journal-title":"Mol Cancer."},{"key":"515_CR2","first-page":"353","volume":"24","author":"AE Russo","year":"2018","unstructured":"Russo AE, Strong VE. Gastric cancer etiology and management in Asia and the West. Annu Rev Med. 2018;24:353\u201367.","journal-title":"Annu Rev Med."},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1038\/s41467-018-06038-y","volume":"03","author":"LY Huang","year":"2018","unstructured":"Huang LY, Zhao J, Chen H, Wan L, Inuzuka H, Guo J, Fu X, Zhai Y, Lu Z, Wang X, Han ZG, Sun Y, Wei W. SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis. Nat Commun. 2018;03:3569.","journal-title":"Nat Commun."},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3904\/kjim.2016.147","volume":"31","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Kim N. Gastric cancer and family history. Korean J Intern Med. 2016;31:1042\u201353.","journal-title":"Korean J Intern Med"},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/bjc.2017.32","volume":"116","author":"X Liang","year":"2017","unstructured":"Liang X, Shi H, Yang L, Qiu C, Lin S, Qi Y, Li J, Zhao A, Liu J. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells. Br J Cancer. 2017;116:903\u201311.","journal-title":"Br J Cancer"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1200\/JCO.2017.76.6493","volume":"28","author":"L Fornaro","year":"2018","unstructured":"Fornaro L, Scartozzi M, Aprile G. CALGB 80101 and the final call for preoperative chemotherapy in gastric cancer. J Clin Oncol. 2018;28:1178\u20139.","journal-title":"J Clin Oncol."},{"key":"515_CR7","first-page":"S1040","volume":"17","author":"HJ Braam","year":"2015","unstructured":"Braam HJ, Schellens JH, Boot H, van Sandick JW, Knibbe CA, Boerma D, van Ramshorst B. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Crit Rev Oncol Hematol. 2015;17:S1040\u20138428.","journal-title":"Crit Rev Oncol Hematol"},{"key":"515_CR8","first-page":"31","volume":"21","author":"A Athauda","year":"2018","unstructured":"Athauda A, Segelov E, Ali Z, Chau I. Integrative molecular analysis of colorectal cancer and gastric cancer: what have we learnt? Cancer Treat Rev. 2018;21:31\u201340.","journal-title":"Cancer Treat Rev"},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","volume":"5","author":"E van Cutsem","year":"2016","unstructured":"van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;5:2654\u201364.","journal-title":"Lancet."},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S1470-2045(18)30512-6","volume":"11","author":"G Roviello","year":"2018","unstructured":"Roviello G, Generali D. Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer. Lancet Oncol. 2018;11:1270\u20132.","journal-title":"Lancet Oncol."},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1470-2045(10)70276-X","volume":"12","author":"J Holden","year":"2011","unstructured":"Holden J, Garrett Z, Stevens A. NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer. Lancet Oncol. 2011;12:16\u20137.","journal-title":"Lancet Oncol."},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/S1470-2045(18)30481-9","volume":"11","author":"J Tabernero","year":"2018","unstructured":"Tabernero J, Hoff PM, Shen L, Ohtsu A, Shah MA, Cheng K, Song C, Wu H, Eng-Wong J, Kim K, Kang YK. Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study. Lancet Oncol. 2018;11:1372\u201384.","journal-title":"Lancet Oncol."},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrgastro.2011.81","volume":"8","author":"L Fornaro","year":"2011","unstructured":"Fornaro L, Lucchesi M, Caparello C, Vasile E, Caponi S, Ginocchi L, Masi G, Falcone A. Anti-HER agents in gastric cancer: from bench to bedside. Nat Rev Gastroenterol Hepatol. 2011;8:369\u201383.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1073\/pnas.1302594110","volume":"14","author":"G Mahlknecht","year":"2013","unstructured":"Mahlknecht G, Maron R, Mancini M, Schechter B, Sela M, Yarden Y. Aptamer to ErbB-2\/HER2 enhances degradation of the target and inhibits tumorigenic growth. Proc Natl Acad Sci USA. 2013;14:8170\u20135.","journal-title":"Proc Natl Acad Sci USA."},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/annonc\/mdt172","volume":"24","author":"D Santini","year":"2013","unstructured":"Santini D, Vincenzi B, Pantano F, Schiavon G, Tonini G. \u2018All action no talk\u2019: the role of HER2\/neu in adjuvant therapy choice for gastric cancer. Ann Oncol. 2013;24:1715\u20137.","journal-title":"Ann Oncol."},{"key":"515_CR16","first-page":"1078","volume":"23","author":"CY Ock","year":"2015","unstructured":"Ock CY, Lee KW, Kim JW, Kim JS, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Kim WH, Bang YJ, Oh DY. Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer. Clin Cancer Res. 2015;23:1078.","journal-title":"Clin Cancer Res"},{"key":"515_CR17","first-page":"0008","volume":"12","author":"CW Espelin","year":"2016","unstructured":"Espelin CW, Leonard SC, Geretti E, Wickham TJ, Hendriks BS. Dual HER2 targeting with trastuzumab and liposome-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer. Cancer Res. 2016;12:0008\u20135472.","journal-title":"Cancer Res"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3322\/caac.21199","volume":"63","author":"AS Thakor","year":"2013","unstructured":"Thakor AS, Gambhir SS. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin. 2013;63:395\u2013418.","journal-title":"CA Cancer J Clin."},{"key":"515_CR19","first-page":"30017","volume":"06","author":"KP Devi","year":"2017","unstructured":"Devi KP, Rajavel T, Daglia M, Nabavi SF, Bishayee A, Nabavi SM. Targeting miRNAs by polyphenols: novel therapeutic strategy for cancer. Semin Cancer Biol. 2017;06:30017\u20131078.","journal-title":"Semin Cancer Biol"},{"key":"515_CR20","first-page":"30020","volume":"07","author":"I Fernandez-Pi\u00f1eiro","year":"2017","unstructured":"Fernandez-Pi\u00f1eiro I, Badiola I, Sanchez A. Nanocarriers for microRNA delivery in cancer medicine. Biotechnol Adv. 2017;07:30020\u20134.","journal-title":"Biotechnol Adv"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nmat3765","volume":"12","author":"R Kanasty","year":"2013","unstructured":"Kanasty R, Dorkin JR, Vegas A, Anderson D. Delivery materials for siRNA therapeutics. Nat Mater. 2013;12:967\u201377.","journal-title":"Nat Mater."},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1021\/acs.nanolett.8b01985","volume":"27","author":"F Wang","year":"2018","unstructured":"Wang F, Gao J, Xiao J, Du J. Dually gated polymersomes for gene delivery. Nano Lett. 2018;27:5562\u20138.","journal-title":"Nano Lett."},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1021\/acs.nanolett.8b00681","volume":"27","author":"RS Riley","year":"2018","unstructured":"Riley RS, Dang MN, Billingsley MM, Abraham B, Gundlach L, Day ES. Evaluating the mechanisms of light-triggered siRNA release from nanoshells for temporal control over gene regulation. Nano Lett. 2018;27:3565\u201370.","journal-title":"Nano Lett."},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"10135","DOI":"10.1021\/acsnano.7b04717","volume":"11","author":"G Kwak","year":"2017","unstructured":"Kwak G, Kim D, Nam GH, Wang SY, Kim IS, Kim SH, Kwon IC, Yeo Y. Programmed cell death protein ligand-1 (PD-L1) silencing with polyethylenimine-dermatan sulfate complex for dual inhibition of melanoma growth. ACS Nano. 2017;11:10135\u201346.","journal-title":"ACS Nano."},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"13612","DOI":"10.1021\/ja047174r","volume":"27","author":"K Itaka","year":"2004","unstructured":"Itaka K, Kanayama N, Nishiyama N, Jang WD, Yamasaki Y, Nakamura K, Kawaguchi H, Kataoka K. Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pKa directed to enhance intracellular gene silencing. J Am Chem Soc. 2004;27:13612\u20133.","journal-title":"J Am Chem Soc"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1039\/c2jm32382f","volume":"22","author":"G Song","year":"2012","unstructured":"Song G, Li C, Hu J, Zou R, Xu K, Han L, Yang J, Chen Z, Qin Z, Ran K, Hu RC, Qian W. A simple transformation from silica core\u2013shell\u2013shell to yolk\u2013shell nanostructures: a useful platform for effective cell imaging and drug delivery. J Mater Chem. 2012;22:17011\u20138.","journal-title":"J Mater Chem."},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1039\/C6BM00449K","volume":"5","author":"C Li","year":"2016","unstructured":"Li C, Hu J, Li W, Song G, Shen J. Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment. Biomater Sci. 2016;5:77\u201388.","journal-title":"Biomater Sci."},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.biomaterials.2013.09.098","volume":"35","author":"J Shen","year":"2014","unstructured":"Shen J, Song G, An M, Li X, Wu N, Ruan K, Hu J, Hu R. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy. Biomaterials. 2014;35:316\u201326.","journal-title":"Biomaterials"},{"issue":"10","key":"515_CR29","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.7150\/thno.24469","volume":"8","author":"S Li","year":"2018","unstructured":"Li S, Liu Y, Rui Y, Tang L, Achilefu S, Gu Y. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system. Theranostics. 2018;8(10):2621\u201333.","journal-title":"Theranostics."},{"key":"515_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7150\/thno.7275","volume":"4","author":"H Ke","year":"2013","unstructured":"Ke H, Wang J, Tong S, Jin Y, Wang S, Qu E, Bao G, Dai Z. Gold nanoshelled liquid perfluorocarbon magnetic nanocapsules: a nanotheranostic platform for bimodal ultrasound\/magnetic resonance imaging guided photothermal tumor ablation. Theranostics. 2013;4:12\u201323.","journal-title":"Theranostics."},{"key":"515_CR31","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1021\/jz501201p","volume":"5","author":"MA Mahmoud","year":"2014","unstructured":"Mahmoud MA. Plasmon resonance hybridization of gold nanospheres and palladium nanoshells combined in a rattle structure. J Phys Chem Lett. 2014;5:2594\u2013600.","journal-title":"J Phys Chem Lett."},{"key":"515_CR32","doi-asserted-by":"publisher","first-page":"1603990","DOI":"10.1002\/smll.201603990","volume":"30","author":"F Zhao","year":"2017","unstructured":"Zhao F, Zhou J, Su X, Wang Y, Yan X, Jia S, Du B. A smart responsive dual aptamers-targeted bubble-generating nanosystem for cancer triplex therapy and ultrasound imaging. Small. 2017;30:1603990.","journal-title":"Small."},{"key":"515_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/smll.201302252","volume":"10","author":"H Ke","year":"2014","unstructured":"Ke H, Yue X, Wang J, Xing S, Zhang Q, Dai Z, Tian J, Wang S, Jin Y. Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound\/CT imaging and photothermal therapy of cancer. Small. 2014;10:1220\u20137.","journal-title":"Small"},{"key":"515_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nprot.2015.039","volume":"10","author":"H Guo","year":"2015","unstructured":"Guo H, Zhu P, Guo F, Li X, Wu X, Fan X, Wen L, Tang F. Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing. Nat Protoc. 2015;10:645\u201359.","journal-title":"Nat Protoc"},{"key":"515_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/emmm.201000099","volume":"2","author":"LA Carragher","year":"2010","unstructured":"Carragher LA, Snell KR, Giblett SM, Aldridge VS, Patel B, Cook SJ, Winton DJ, Marais R, Pritchard CA. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010;2:458\u201371.","journal-title":"EMBO Mol Med."},{"key":"515_CR36","first-page":"1711950115","volume":"02","author":"B Ingelsson","year":"2018","unstructured":"Ingelsson B, S\u00f6derberg D, Strid T, S\u00f6derberg A, Bergh AC, Loitto V, Lotfi K, Segelmark M, Spyrou G, Ros\u00e9n A. Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C. Proc Natl Acad Sci USA. 2018;02:1711950115.","journal-title":"Proc Natl Acad Sci USA."},{"key":"515_CR37","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1038\/s41467-018-06482-w","volume":"9","author":"M Arechederra","year":"2018","unstructured":"Arechederra M, Daian F, Yim A, Bazai SK, Richelme S, Dono R, Saurin AJ, Habermann BH, Maina F. Publisher correction: hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer. Nat Commun. 2018;9:3976.","journal-title":"Nat Commun."}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0515-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-019-0515-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0515-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T19:05:59Z","timestamp":1593803159000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-019-0515-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1186\/s12951-019-0515-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"6 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were carried out in compliance with the Animal Management Rules of the Ministry of Health of the People\u2019s Republic of China (Document No. 55,2001) and the guidelines for Care and Use of Laboratory Animals of Jilin University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The paper was consented for publication by all the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}